Physician profile
Leonardo Protasio Oliveira
NPI 1871765958
$63,672.54
in general payments reported to CMS, 2019-2025
11 companies · $2,112 in 2025
The $2,112 reported for 2025 was more than what 98% of Sports Medicine (Internal Medicine) providers received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $59.28 · 2021: $2,399 · 2022: $11K · 2023: $37K · 2024: $11K · 2025: $2,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Consulting Fee: $15K · Travel and Lodging: $14K · Food and Beverage: $1,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,118.75 |
| Consulting Fee | $15,372.50 |
| Travel and Lodging | $14,443.11 |
| Food and Beverage | $1,544.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $33,641.35 | 2023-2025 | L360 Thigh System, Tenex Health Tx, L360 Thigh System |
| Trice Medical, INC. | $25,830.98 | 2022-2025 | |
| Tenex Health INC. | $2,505.33 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $877.14 | 2023-2024 | Iovera |
| Depuy Synthes Sales INC. | $347.80 | 2024-2025 | Monovisc, Orthovisc |
| Hydrocision, INC. | $168.46 | 2025 | Tenjet |
| Djo, LLC | $155.70 | 2019-2025 | Cmf |
| Terumo Bct, INC. | $63.89 | 2022 | |
| Abbvie INC. | $34.19 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $26.70 | 2025 | |
| Novo Nordisk INC | $21.00 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonardo Oliveira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.